Skip to main content
Kenneth Shain, MD, Hematology, Tampa, FL

KennethHShainMD

Hematology Tampa, FL

Hematologic Oncology, Myeloproliferative Disorder Hematology-Oncology

Associate Member Moffitt Cancer Center

Overview of Dr. Shain

Dr. Kenneth Shain is a hematologist in Tampa, FL and is affiliated with H. Lee Moffitt Cancer Center and Research Institute. He received his medical degree from University of South Florida Morsani College of Medicine and has been in practice 11 years. He is one of 46 doctors at H. Lee Moffitt Cancer Center and Research Institute who specialize in Hematology. He has more than 100 publications and over 500 citings.

Education & Training

  • University of South Florida Morsani
    University of South Florida MorsaniFellowship, Hematology and Medical Oncology, 2008 - 2011
  • University of South Florida Morsani
    University of South Florida MorsaniResidency, Internal Medicine, 2006 - 2008
  • University of South Florida College of Medicine
    University of South Florida College of MedicineClass of 2006

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2010 - 2026

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Depth of Response to Daratumumab (DARA), Lenalidomide, Bortezomib, and Dexamethasone (RVd) Improves over Time in Patients (pts) with Transplant-Eligible Newly Diagnose...
    Kenneth H. Shain, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • The Result of a Phase 1 Study of Selinexor in Combination with High-Dose Melphalan and Autologous Hematopoietic Cell Transplantation for Multiple Myeloma
    Kenneth H. Shain, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Composition of Immune Subpopulations Influence Multiple Myeloma Disease Progression
    Kenneth H. Shain, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Join now to see all

Lectures

  • Pharmacodynamical Modeling of Two-Way Synergistic Effect for High-Throughput Drug Combination Screening in an Ex Vivo Reconstruction of Bone Marrow Using Primary Multi... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • Proteasome Inhibitors Paving Promising Path for Myeloma Treatment
    Proteasome Inhibitors Paving Promising Path for Myeloma TreatmentJuly 17th, 2017